These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1024451)

  • 1. [Reactogenicity and immunologic effectiveness of cholerogen-anatoxin. Feasibility of revaccination with cholerogen-anatoxin, determination of optimal doses and times for administration].
    Sumarokov AA; Ivanov NR; Lelikov VL; Dzhaparidze MN; Karaeva LT
    Zh Mikrobiol Epidemiol Immunobiol; 1976; (12):85-91. PubMed ID: 1024451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reactogenicity and immunological effectiveness of an oral cholera chemical vaccine in a limited controlled experiment with human revaccination].
    Sumarokov AA; Ivanov NR; Lelikov VL; Dzhaparidze MN; Karaeva LT
    Zh Mikrobiol Epidemiol Immunobiol; 1978; (12):87-92. PubMed ID: 371293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristics of the immunogenic properties of cholerogen-anatoxin according to gel precipitation reactions and quantity of reducing sugars].
    Dzhaparidze MN; Martens LA; Egorova VD; Karaeva LT; Derteva II
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Jun; (6):48-51. PubMed ID: 808056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Standardization of chemical cholerogen-toxoid cholera vaccine according to the content of somatic O-antigen].
    Sumarokov AA; Dzhaperidze MN; Ivanov NR; Karaeva LT; Popov AA
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Apr; (4):99-106. PubMed ID: 405829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of revaccination in persons inoculated primarily with whole-cell and toxoid cholera vaccines].
    Kiseleva IE; Domaradskiĭ IV; Erokhin EP; Kirdeev VK; Kiseleva VI
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Jun; 51(6):64-7. PubMed ID: 4409388
    [No Abstract]   [Full Text] [Related]  

  • 6. [Testing the immunologic effectiveness of cholerogen-toxoid on volunteers].
    Dzhaparidze MN; Karaeva LT; Derteva II; Marchuk IM; Anokhina SV
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Aug; (8):106-9. PubMed ID: 4450864
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunogenic properties of cholerogen-toxoid and killed corpuscular vaccine in acute experiments on guinea pigs].
    Nepogodin NF
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Jul; (7):87-90. PubMed ID: 696096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunologic efficacy of cholerogen-anatoxin in tests on experimental animals].
    Dzhaparidze MN; Karaeva LT; Derteva II; Marchuk LM; Anokhina SV
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Mar; 51(3):58-61. PubMed ID: 4830045
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of the immunogenicity and immunological effectiveness of choleragen anatoxin. (data from a controlled epidemiological experiment). 3. The determination of the optimum inoculation doses of choleragen anatoxin for the immunization of children of different ages and of adolescents].
    Sumarokov AA; Lelikov VL; Ivanov NR; Poliakov KA; Dzhaparidze MH
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Dec; (12):32-8. PubMed ID: 4616552
    [No Abstract]   [Full Text] [Related]  

  • 10. Response of man to infection with Vibrio cholerae. II. Protection from illness afforded by previous disease and vaccine.
    Cash RA; Music SI; Libonati JP; Craig JP; Pierce NF; Hornick RB
    J Infect Dis; 1974 Oct; 130(4):325-33. PubMed ID: 4443613
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunochemical and biochemical characteristics of a preventive preparation against cholera, cholerogen-toxoid].
    Dzhaparidze MN; Sumarokov AA; Martens LA; Egorova VD; Karaeva LT
    Zh Mikrobiol Epidemiol Immunobiol; 1976 May; (5):32-7. PubMed ID: 941601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity in experimental cholera: effect of parenteral immunization with vaccines and toxoid.
    Sinha VB; Bhaskaran K
    Bull World Health Organ; 1973; 49(6):605-13. PubMed ID: 4548387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response of the intestinal mucosa to cholera toxoid.
    Pierce NF; Sack RB
    J Infect Dis; 1977 Aug; 136 Suppl():S113-7. PubMed ID: 894085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of the immunogenicity and immunological effectiveness of choleragen anatoxin (data from a controlled epidemiological experiment). II. The cahracterisitcs of choleragen anatoxin immunogenicity compared with corpuscular cholera vaccines administered by syringe and by using a jet injector].
    Sumarokov AA; Lelikov VL; Dzhaparidze MN; Karaeva LT; Derteva II
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Nov; (11):31-7. PubMed ID: 4615518
    [No Abstract]   [Full Text] [Related]  

  • 15. [Study of the immunogenicity and immunological effectiveness of choleragen anatoxin (data from a controlled epidemiological experiment). I. The characteristics of choleragen anatoxin compared wiht corpuscular cholera vaccines administered by syringe and by using a jet injector].
    Lelikov VL; Sumarokov AA; Ivanov NR; Fedenev VG; Poliakov KA
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Nov; (11):25-30. PubMed ID: 4615517
    [No Abstract]   [Full Text] [Related]  

  • 16. [A study of immunological efficacy of the oral chemical cholera vaccine on experimental animals].
    Dzhaparidze MN; Egorova VD; Karaeva LT; Sumarokov AA; Gor'kova Av
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Nov; (11):115-9. PubMed ID: 1007720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The determination of the optimal inoculation dose of an oral cholera bivalent chemical vaccine in a controlled trial of the vaccination of children and adolescents].
    Sumarokov AA; Dzhaparidze MN; Eliseev IuIu; Nikitina GP; Poliakov KA; Kazakova ES; Meleshchenko MV; Tsareva NM; Reznikov IuB; Adamova GV
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (5):55-60. PubMed ID: 8067145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of reactions and serological response to cholera vaccines in a controlled field trial conducted in the USSR.
    Burgasov PN; Sumarokov AA; Lelikov VL; Marcuk LM; Fedenev VG; Dzaparidze MN; Karaeva LT; Derteva II
    Bull World Health Organ; 1976; 54(2):163-70. PubMed ID: 798636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenicity of cholera toxoid in humans.
    Germanier R; Fürer E; Varallyay S; Inderbitzin TM
    J Infect Dis; 1977 Apr; 135(4):512-6. PubMed ID: 856918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of Vibrio antibody titers during anti-cholera vaccination].
    Dirimci OT; Cinar V
    Turk Hij Tecr Biyol Derg (1961); 1973; 33(2-3):118-28. PubMed ID: 4807572
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.